MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 10-29-2024
10x Genomics Accounts Payables 2011-2025 | TXG
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables 10x Genomics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.7 M | 21.6 M | 17.4 M | 4.71 M | 13 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.6 M | 4.71 M | 14.5 M |
Quarterly Accounts Payables 10x Genomics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.2 M | 21.2 M | 20.2 M | - | - | 29.3 M | 21.6 M | - | 26.7 M | 19 M | 17.4 M | 17 M | 16.2 M | 15.6 M | 4.71 M | 4.71 M | 4.71 M | 4.71 M | 13 M | 13 M | 13 M | 13 M | 8.79 M | 8.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.3 M | 4.71 M | 15.2 M |
Accounts Payables of other stocks in the Health information services industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
330 M | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
10.1 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
442 M | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
7.39 M | - | 0.29 % | $ 206 M | USA |
 |
Change Healthcare
CHNG
|
104 M | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
57.2 M | $ 4.11 | -0.48 % | $ 385 M | USA |
 |
Health Catalyst
HCAT
|
11.4 M | $ 2.34 | -4.82 % | $ 141 M | USA |
 |
HealthStream
HSTM
|
6.63 M | $ 24.4 | 0.95 % | $ 741 M | USA |
 |
iCAD
ICAD
|
1.11 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
5.51 M | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
12 M | $ 96.06 | -0.75 % | $ 8.22 B | USA |
 |
OptimizeRx Corporation
OPRX
|
2.23 M | $ 13.18 | -1.35 % | $ 226 M | USA |
 |
American Well Corporation
AMWL
|
5.02 M | $ 4.68 | 1.3 % | $ 70.2 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
16.8 M | - | -10.39 % | $ 886 M | USA |
 |
Progyny
PGNY
|
95.1 M | $ 26.39 | -1.2 % | $ 2.26 B | USA |
 |
Premier
PINC
|
19.6 M | $ 28.26 | - | $ 2.33 B | USA |
 |
MTBC
MTBC
|
4.56 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
14.1 M | $ 2.72 | -3.72 % | $ 1.05 B | USA |
 |
Schrödinger
SDGR
|
10.7 M | $ 18.41 | 1.99 % | $ 1.34 B | USA |
 |
Omnicell
OMCL
|
51.8 M | $ 43.31 | -1.25 % | $ 1.99 B | USA |
 |
1Life Healthcare
ONEM
|
18.7 M | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
8.48 M | $ 16.68 | 2.71 % | $ 910 M | USA |
 |
Signify Health
SGFY
|
84.1 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
17.7 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
10.4 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
11.4 M | - | - | $ 1.6 B | USA |
 |
Veeva Systems
VEEV
|
31.5 M | $ 219.17 | -1.81 % | $ 35.2 B | USA |
 |
Zhongchao
ZCMD
|
535 K | $ 0.58 | -3.18 % | $ 3.02 M |  China |
 |
Streamline Health Solutions
STRM
|
1.54 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
33.1 M | $ 7.36 | -2.65 % | $ 1.26 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.5 M | - | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
600 K | $ 0.21 | 5.86 % | $ 306 K | USA |